Login

Joseph Chen, CEO of Renren Inc., discusses the Chinese social-networking site's recent $855 million completion. 00:10:00

Share On Facebook Share On Twitter

Joseph Chen and Chen Ji are the CEOs of Renren.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Insights into Current Trends and Opportunities in the Global Mining Market
00:10:00
"2024 Global Investment Outlook | Insights from BlackRock's Wei Li"
00:10:00
Business as a Force for Good: Sir Paul Marshall's Insights from INSEAD's Doriot Distinguished Speaker Series | Paul Marshall - Marshall Wace
00:00:00
Dr. David Sinclair, Professor in Genetics, Harvard Medical School
00:10:00
Traversing the Realm of Commercial Real Estate and REIT Management | Jennifer Francis, President ,Diversified Healthcare Trust.
00:10:00
Discover Money Concepts: A Proven Profit Model in Financial Services
00:10:00
The Firm is backed by a well-diversified pool of investors, endowments, foundations, and executives from the world’s top technology|Will Price,Founder & General Partner,Next Frontier Capital
00:10:00
Utah Legal Services Enhances Employee Benefits with Personalized Retirement Support from Mutual of America
00:10:00
Sim Shabalala Discusses Standard Bank's Strategic Vision and Economic Insights | Sim Tshabalala, CEO, Standard Bank.
00:10:00
leading investments in transformative companies building in future tech|Mike Ghaffary,General Partner,Canvas Ventures
00:10:00
improve the health of people and planet.|Harsh Patel,Co-Founder and Managing Partner,Wireframe Ventures
00:10:00
Grindrod Reports 26% Rise in Earnings, Records Record Port Volumes | Xolani Mbambo - CEO of Grindrod Limited

© 2026 Nehu